๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

Fecal Microbiota Transplantation

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 13 trials in our China register that name Fecal Microbiota Transplantation as an intervention. Synced 24 Sep 2026
13Trials tracked
9Recruiting now
12Lead sponsors
1Country register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards

Fecal Microbiota Transplantation is named as a drug or biological intervention in 13 clinical trials in our China trial register, 9 of which are recruiting. Lead sponsors include Air Force Military Medical University, China (2), Second Affiliated Hospital, Zhejiang University, School of Medicine (1) and Sixth Affiliated Hospital, Sun Yat-sen University (1). Registered phases: Not applicable, Phase 2, Phase 1/2, Phase 1 and Phase EARLY_PHASE1. Conditions studied include Hepatic Encephalopathy; Fecal Microbiota Transplantation; TIPS.

01

Clinical trials of Fecal Microbiota Transplantation

13 trials
NCT IDStudyPhaseStatusLead sponsorRegister
NCT07683936 Fecal Microbiota Transplantation for the Treatment of Refractory Hepatic Encephalopathy After TIPS Surgery (ClinicalTrials.gov ↗)
Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS
Phase EARLY_PHASE1 Recruiting Air Force Military Medical University, China China
NCT06776029 Fecal Microbiota Transplantation for Radiation-Induced Proctopathy (ClinicalTrials.gov ↗)
Radiation Induced Proctitis
Phase 2 Recruiting Sixth Affiliated Hospital, Sun Yat-sen University China
NCT07463248 PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy (ClinicalTrials.gov ↗)
Hepatocellular Carcinoma (HCC)
Phase 2 Recruiting Wang Xin China
NCT07814456 Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors (ClinicalTrials.gov ↗)
Ulcerative Colitis (UC), Inflammatory Bowel Disease
Phase 2 Recruiting First Affiliated Hospital of Kunming Medical University China
NCT07319364 A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects (ClinicalTrials.gov ↗)
Fecal Microbiota Transplantation (FMT), Gastrointestinal Neoplasms, Antineoplastic Agents
Phase 1 Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine China
NCT05321758 Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease (ClinicalTrials.gov ↗)
Crohn Disease
Not applicable Recruiting Tongji Hospital China
NCT06496412 Safety and Efficacy of Fecal Microbiota Transplantation on Cognitive Function in T1DM (ClinicalTrials.gov ↗)
Type 1 Diabetes
Not applicable Recruiting Second Xiangya Hospital of Central South University China
NCT07464392 FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis (ClinicalTrials.gov ↗)
Acute Pancreatitis
Not applicable Recruiting Changhai Hospital China
NCT07746635 Fecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian Syndrome (ClinicalTrials.gov ↗)
PCOS (Polycystic Ovary Syndrome)
Not applicable Recruiting Shanghai Changzheng Hospital China
NCT07454408 Evaluation of the Outcome of Fecal Microbiota Transplantation (ClinicalTrials.gov ↗)
Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS
Phase 1/2 Not yet open Air Force Military Medical University, China China
NCT07755319 Safety and Feasibility of FMT for Immune Recovery After HSCT (ClinicalTrials.gov ↗)
Humoral Immunodeficiency, Hematopoietic Stem Cell Transplantation
Phase 1/2 Not yet open The First Affiliated Hospital of Soochow University China
NCT07599046 Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes (ClinicalTrials.gov ↗)
Obesity Type 2 Diabetes Mellitus
Not applicable Not yet open Eighth Affiliated Hospital, Sun Yat-sen University China
NCT07733037 Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia (ClinicalTrials.gov ↗)
Immune Thrombocytopenia (ITP)
Phase 2 Active, closed Peking University People's Hospital China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied

20 conditions
Condition (as registered)Trials
Hepatic Encephalopathy2
Fecal Microbiota Transplantation2
TIPS2
Fecal Microbiota Transplantation (FMT)1
Gastrointestinal Neoplasms1
Antineoplastic Agents1
Drug-related Side Effects and Adverse Reactions1
Radiation Induced Proctitis1
PCOS (Polycystic Ovary Syndrome)1
Type 1 Diabetes1
Acute Pancreatitis1
Humoral Immunodeficiency1
Hematopoietic Stem Cell Transplantation1
Immune Thrombocytopenia (ITP)1
Refractory Hepatic Encephalopathy1
Hepatocellular Carcinoma (HCC)1
Crohn Disease1
Ulcerative Colitis (UC)1
Inflammatory Bowel Disease1
Obesity Type 2 Diabetes Mellitus1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
Air Force Military Medical University, China2
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Sixth Affiliated Hospital, Sun Yat-sen University1
Shanghai Changzheng Hospital1
Second Xiangya Hospital of Central South University1
Changhai Hospital1
The First Affiliated Hospital of Soochow University1
Peking University People's Hospital1
Wang Xin1
Tongji Hospital1
First Affiliated Hospital of Kunming Medical University1
Eighth Affiliated Hospital, Sun Yat-sen University1
04

Trials by country register

RegisterFecal Microbiota Transplantation trials
Clinical trials in China13

A trial with sites in more than one country appears in each of those registers.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how Fecal Microbiota Transplantation works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Fecal Microbiota Transplantation (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.